About Dxcover

Dxcover is a clinical stage diagnostics company developing AI powered liquid biopsy technology for the early detection of multiple high mortality cancers. The company's PANAROMIC platform uses multi-omic spectral analysis combining light and machine learning to rapidly analyse blood serum samples, detecting disease signals that traditional methods miss. The technology targets high-risk populations for cancers including brain tumours, colorectal, lung and pancreatic cancers. Dxcover aims to democratise cancer care by providing fast, cost effective diagnostic services that improve survival rates and quality of life for patients across the US, UK and EU markets.